Ceralasertib
Ceralasertib (AZD6738) is an orally active and bioavailable inhibitor of ATR kinase with an IC50 of 1 nM.
Product Specifications
CAS Number
[1352226-88-0]
Product Name Alternative
AZD6738
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
ATM/ATR
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; PI3K/Akt/mTOR
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/AZD6738.html
Purity
99.76
Solubility
DMSO : 70 mg/mL (ultrasonic)
Smiles
O=[S@@](C1(CC1)C2=NC(C3=C4C(NC=C4)=NC=C3)=NC(N5CCOC[C@H]5C)=C2)(C)=N
Molecular Formula
C20H24N6O2S
Molecular Weight
412.51
Precautions
H302, H315, H319, H335
References & Citations
[1]Vendetti FP, et al. The orally active and bioavailable ATR kinase inhibitor AZD6738 potentiates the anti-tumor effects of CDDP to resolve ATM-deficient non-small cell lung cancer in vivo.|[2]Kim HJ, et al. Anti-tumor activity of the ATR inhibitor AZD6738 in HER2 positive breast cancer cells. Int J Cancer. 2017 Jan 1;140 (1) :109-119.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 3
Isoform
ATR
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
302785-HRP 200 µL
TAF7L (Transcription initiation Factor TFIID Subunit 7-like, Cancer/Testis antigen 40, CT40, RNA Polymerase II TBP-Associated Factor Subunit Q, TATA box-Binding Protein-Associated Factor 50kD, Transcription initiation Factor TFIID 50kD Subunit, TAF7L, TAF2Q) (HRP) discontinued
Ask
View Details